[1]
“Active surveillance of adverse events following ChAdOx1 nCoV-19 immunization in geriatric population: a prospective multi-centric study from Jaipur, Rajasthan, India”, Geriatr Care, vol. 7, no. 3, Jan. 2022, doi: 10.4081/gc.2021.9908.